Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacologic interventions targeting ovarian aging, cancer, and mitochondrial dysfunction: An updated evidence.

Biochimica et biophysica acta. Molecular basis of disease·2025
Same author

Nutritional Factors Affecting Magnesium Bioavailability: A Narrative Review.

Biological trace element research·2025
Same author

Editorial: Maternal-fetal interface: new insight in placenta research, volume II.

Frontiers in endocrinology·2025
Same author

Magnesium sulfate in oxidative stress-associated pathologies: clinical, cellular, and molecular perspectives.

Biophysical reviews·2025
Same author

Antioxidant Activity of MgSO<sub>4</sub> Ion Pairs by Spin-Electron Stabilization of Hydroxyl Radicals through DFT Calculations: Biological Relevance.

ACS omega·2024
Same author

Editorial: Maternal-fetal interface: new insight in placenta research.

Frontiers in endocrinology·2023
Same journal

Cardiovascular disease and miRNA.

Advances in clinical chemistry·2026
Same journal

RNA biomarkers in antidoping.

Advances in clinical chemistry·2026
Same journal

Advances in microfluidic extracellular vesicle technology.

Advances in clinical chemistry·2026
Same journal

Chronic low-grade inflammation in vegetarians and vegans: Biomarker evidence and methodological considerations.

Advances in clinical chemistry·2026
Same journal

Biomarkers in heart failure.

Advances in clinical chemistry·2026
Same journal

Advances in small extracellular vesicle analysis.

Advances in clinical chemistry·2026
See all related articles

Related Experiment Video

Updated: Jun 25, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Biomarkers for assessing magnesium status.

Lusliany J Rondón1, Reinaldo Marín2

  • 1Center for Biophysics and Biochemistry (CBB), Venezuelan Institute for Scientific Research (IVIC), Caracas, Venezuela; Biochemistry Department, School of Nutrition and Dietetics, Central University of Venezuela (UCV), Caracas, Venezuela.

Advances in Clinical Chemistry
|June 23, 2026
PubMed
Summary
This summary is machine-generated.

Assessing magnesium status is challenging due to its intracellular nature. Current biomarkers are limited, necessitating the development of novel, accurate methods for detecting magnesium deficiency and guiding clinical decisions.

Keywords:
BiomarkersClinical researchExperimental researchLaboratory testsMagnesiumMagnesium status

More Related Videos

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

An Anaerobic Biosensor Assay for the Detection of Mercury and Cadmium
09:33

An Anaerobic Biosensor Assay for the Detection of Mercury and Cadmium

Published on: December 17, 2018

Related Experiment Videos

Last Updated: Jun 25, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

An Anaerobic Biosensor Assay for the Detection of Mercury and Cadmium
09:33

An Anaerobic Biosensor Assay for the Detection of Mercury and Cadmium

Published on: December 17, 2018

Area of Science:

  • Biochemistry
  • Physiology
  • Clinical Diagnostics

Background:

  • Magnesium (Mg) is vital for over 600 enzymatic reactions and multiple physiological systems.
  • Accurate assessment of Mg status is difficult due to its intracellular distribution.
  • Existing methods often fail to detect subclinical magnesium deficiency.

Purpose of the Study:

  • To review current and novel biomarkers for assessing magnesium status.
  • To discuss the limitations of existing magnesium assessment methods.
  • To highlight the need for improved diagnostic tools for magnesium deficiency.

Main Methods:

  • Examination of current Mg status measures: serum/plasma, ionized Mg, urine.
  • Review of intracellular measurements: red blood cells, leukocytes, platelets.
  • Analysis of non-invasive sampling (hair, nails) and functional tests (Mg loading, balance studies).
  • Discussion of novel approaches: Mg Depletion Score (MDS), genetic biomarkers, pregnancy-specific applications.

Main Results:

  • No single biomarker reliably reflects whole-body magnesium status.
  • Serum Mg levels may not detect subclinical deficiency.
  • Combination approaches and novel biomarkers show promise for improved accuracy.

Conclusions:

  • Current methods for assessing magnesium status have significant limitations.
  • Novel biomarkers and functional tests are crucial for accurate diagnosis.
  • Future research should focus on developing sensitive, minimally invasive biomarkers for magnesium deficiency.